MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2026 All rights reserved. Tickeron Inc.
RGLS
Stock ticker:
PRICE
CHANGE
CAPITALIZATION

Regulus Therapeutics (RGLS) Ownership - Who owns Regulus Therapeutics?

Regulus Therapeutics Inc is a biotechnology company focused on the development of microRNA therapies... Show more

#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
Pharmaceuticals Other
Address
4224 Campus Point Court
Phone
+1 858 202-6300
Employees
30
Web
https://www.regulusrx.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
564.95M
P/E Ratio
N/A
Total Cash
65.37M
Projected Growth
N/A
Total Debt
1.4M
Revenue
N/A
Risk (Beta)
-0.51
Dividend Yield
N/A
Total Cash/Share
0.94
Total Debt/Equity
14.52
Revenue/Share
null USD as % of share price
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
View AI-Driven Trading for RGLS
A.I. Advisor
published General Information

General Information

a developer of pharmaceutical products

Industry Biotechnology

Profile
Details
Industry
Pharmaceuticals Other
Address
4224 Campus Point Court
Phone
+1 858 202-6300
Employees
30
Web
https://www.regulusrx.com